The blood levels of t-tau are still controversial in terms of predictability of tau pathology and neurodegeneration in the brain, however, t-tau and p-tau are considered better blood biomarkers for AD, and the conversion from MCI to AD (Mielke et al., 2017; Zetterberg, 2017). The gene discussed is MAPT; the disease is Alzheimer disease.